PATIENCE DAVID (Chief Financial Officer) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/25/2025ACC: 0001970009-25-000004
Officer· Chief Financial Officer
Since Feb 2026
+195K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
195K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+65K
Price / share
—
Trade value
—
% of position
32.5%
11/24/2025
200K→265K
Total
Net shares
+65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2025 | A · Award | +65K | — | — | 32.5% | 200K | 265K |
| Total | +65K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
130K shares
Shares
+130K
Strike price
5.55
Held after
668.90K
Exercisable
—
11/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock130K shares | 11/24/2025 | A · Award | +130K | 5.55 | — | 668.90K |